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Abstract 
The cloned cDNA for rat thromboxane (TX) synthase with a size of 1851 bp contained a 1599-bp open reading frame which encoded a 533-amino 
acid protein sharing 79.7% identity with human TX synthase. RNA blot analysis was carried out with rat cells and tissues. Rat peritoneal macrophages 
most abundantly expressed mRNA for TX synthase, and its level was not changed by in vivo stimulation of casein. Bone marrow, spleen, lung and 
thymus also expressed the TX synthase gene. These findings suggest he possibility that TXA, plays a role in the immune system. 
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1. Introduction 2. Materials and methods 
Thromboxane (TX) A,, a labile metabolite of ara- 
chidonic acid, promotes platelet aggregation and con- 
tracts vascular smooth muscle and glomerular mesangial 
cells [ 1,2], and has been implicated as a mediator in 
cardiovascular diseases, bronchial asthma, glomeru- 
lonephritis, etc. [3,4]. In the lesions of these diseases, 
macrophage infiltration is often observed [5,6], suggest- 
ing the involvement of macrophage-derived TXA, in the 
diseases. Recently, we succeeded in the cloning and ex- 
pression of human platelet TX synthase cDNA, and 
demonstrated that the primary structure of the enzyme 
exhibited characteristics of cytochrome P450 [7,8]. We 
also found that the level of TX synthase mRNA in 
human erythroleukemia (HEL) cells was enhanced by 
phorbol ester [93. For a better understanding of the pa- 
thogenesis of the diseases described above it is valuable 
to know about gene expression of TX synthase in macro- 
phages. On the other hand. rats are frequently used as 
experimental models of cardiovascular diseases and 
glomerulonephritis. In this communication we report the 
cloning of rat TX synthase cDNA and the expression of 
the TX synthase gene in peritoneal macrophages, blood 
cells and tissues from rats. 
2.1. Molecular cloning and characterization of rat TX synthase cDNA 
A rat megakaryocyte cDNA @gtl 1) library was kindly provided by 
Dr. T. Doi (Osaka University). The probe for screening of the library 
was human platelet TX synthase cDNA (pHPTXS2 and pHPTXS6, [7]) 
radiolabeled with [a-“P]dCTP (Amersham) by the random-priming 
method [lo]. Screening of the library was performed according to stand- 
ard protocols [1 11. Hybridization was carried out overnight at 60°C and 
the membranes were washed at 55°C for 40 min in 1 x SSC (0.15 M 
NaCl and 15 mM sodium citrate, pH 7.0) containing 0.1% SDS. A 
positive clone (pRTXS1) was isolated and the cDNA insert excised by 
EcoRI digestion was ligated into pBluescript II SK(-). For polymerase 
chain reaction (PCR) cloning of the remaining 3’-region of the cDNA, 
the first strand cDNA was synthesized with 70 pmol of a dT,,-adaptor 
(5’-GACTCGAGTCGACTCGA(T),,33 and the 1 ,ug of poly(A)’ 
RNA prepared from peritoneal cells of Sprague-Dawley (SD) rats, 
which were intraperitoneally administered with peptone (3.75 mgikg) 
4 days before isolation. Amplification was performed with the adaptor 
primer and the Pl primer (5’-GACATGATCAAGGAGGTGTT- 
GGTT-3’, nucleotide residues 280-304) synthesized according to the 
nucleotide sequence of the clone pRTXS1. The conditions for PCR 
amplification were as follows: denaturation at 94°C for 40 s, annealing 
at 55°C for 1 min and extension at 72’C for 3 min for a total of 30 
cycles. After DNA blot analysis with the human TX synthase cDNA 
probe, the PCR product was purified and cloned into pBluescript II 
SK(-). The isolated clone pRTXS2-2 was ligated with the clone 
pRTXS1 at the BcZl site to yield pRTXS3. 
The DNA sequence was determined by the method of Sanger [12] 
using a BcaBEST DNA sequencing kit (Takara Shuzo Co.), or a Taq 
dye primer cycle sequencing kit on a model 373A DNA sequencer 
(Applied Biosystems Inc.). Computer analysis was performed with the 
aid of the SDC-GENETYX program supplied by Software Develop- 
ment Co. (Tokyo). 
*Corresponding author. Fax: (81) (6) 872 7485. 
Abbreviations: TX, thromboxane; PCR, polymerase chain reaction; 
SD, Sprague-Dawley; bp, base pair(s); kb, kilobase pair(s). 
2.2. RNA blot analysis 
The blood collected with EDTA from SD rats was centrifuged at 500 
x g for 5 min at room temperature to separate the platelet-rich plasma 
and buffy coat from erythrocytes, and each of the two cell fractions 
were centrifuged at 1000 x g for 15 min (131. Total RNAs of platelets 
and leukocytes were then isolated from each sediment. Peritoneal cells 
were isolated from 6- to 7-week-old male SD rats weighing about 200 
g at day 1, 4 or 8 after an intraperitoneal injection of casein (0.75 
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mg/rat) in 15 ml of 0.9% NaCl[14]. The macrophage content in isolated 
peritoneal cells was estimated under a microscope by counting the 
number of cells stained by the Giemsa staining method. Total RNAs 
were isolated according to the acid guanidium thiocyanate procedure 
[15] and poly(A)’ RNA was purified by oligo(dT),,-latex (Nippon 
Roche). Total RNAs of rat tissues were prepared from normal 3- to 
5-week-old male/female SD rats. 5 pg of poly(A)’ RNA from each 
tissue and 20 pg of total RNA from blood cells and peritoneal cells were 
electrophoresed on a 1.0% agarose gel containing 1.5% formaldehyde, 
and transferred to a nylon membrane. Hybridization was carried out 
using rat 3’P-labeled TX synthase cDNA overnight as described in [9], 
and the membrane was washed at 65°C for 40 min in 0.1 x SSC 
containing 0.1% SDS. 
3. Results and discussion 
3.1. Cloning and sequencing of rat TX synthase cDNA 
A TX synthase cDNA clone (pRTXS1) was isolated 
by screening of 3 x lo5 clones of a rat megakaryocyte 
cDNA library (agtl 1) with a human TX synthase cDNA 
as a probe. The isolated rat clone contained a 464-bp 
insert covering the 131-bp S-untranslated region and 
333-bp protein-coding region. On RNA blot analysis 
using the pRTXS 1 insert as a probe, the mRNA from rat 
peritoneal cells, mostly macrophages gave very intense 
signals. Therefore, the remaining 3’-downstream region 
of the TX synthase cDNA was amplified by the PCR 
technique using the cDNAs prepared with poly(A)’ 
RNA from rat peritoneal cells. This amplified cDNA 
clone (pRTXS2-2) contained a 1536-bp insert including 
a polyadenylation motif AATAAA (nucleotides 1700- 
1705) and a poly(A),, tract. The inserts of the two cDNA 
clones totally covered a 1851-bp sequence of the cDNA 
for rat TX synthase (Fig. 1A). The full length of rat TX 
synthase cDNA contained a 1599-bp open reading frame 
encoding a 533-amino acid protein which has a calcu- 
lated molecular weight of 59,974 Da (Fig. 1B). The result 
of the protein homology search demonstrated that rat 
TX synthase xhibited a 79.7% similarity with the human 
enzyme [7,16] and a 85.4% similarity with the mouse 
enzyme [17]. The amino acid sequence FGAGPRSCLG 
(residues 472-481) around the specific cysteine residue, 
which probably constitutes the fifth ligand of heme, was 
completely conserved among rat, human and mouse. 
The amino acid sequence from residue 77 to 87 of rat TX 
synthase was completely identical to that of human TX 
synthase, but was entirely different from that of mouse 
TX synthase, although the corresponding nucleotide se- 
quences of rat and mouse enzymes showed a high simi- 
larity. The 3’-untranslated region of rat TX synthase 
cDNA was approximately 60 bp shorter than that of 
human and approximately 90 bp shorter than that of 
mouse. 
3.2. Tissue expression of the rat TX synthase gene 
Using a full-length rat TX synthase cDNA (pRTXS3) 
as a probe, RNA blot analysis was carried out to inves- 
tigate the expression of TXS mRNA in rat blood cells 
and peritoneal cells. TX synthase mRNA was expressed 
in small amounts in platelets and leukocytes as shown in 
Fig. 2A. The result was different from a previous obser- 
vation that a relatively high level of TX synthase mRNA 
was detected in human platelets [7]. However, the ob- 
served low level of TX synthase mRNA in rat platelets 
agreed with a low TX synthase activity determined in rat 
platelets [18]. A more detailed study is necessary to ex- 
plain the different levels of TX synthase mRNA in 
human and rat. Interestingly, a large quantity of TX 
synthase mRNA was observed in rat peritoneal resident 
cells. We examined the effect of in vivo stimulation by 
casein on the mRNA level of peritoneal cells, because 
casein, as well as peptone, was effective to elicit macro- 
phages. The mRNA level of TX synthase in peritoneal 
cells decreased one day after the intraperitoneal injection 
of casein, then increased to a level higher than that of 
resident cells during the following 3 days and went back 
to the level of resident cells 4 days later (Fig. 2A). On the 
other hand, the cellular population of macrophage was 
70% in resident cells and decreased to 35% in peritoneal 
cells isolated one day after casein injection; most of the 
residual cells were polymorphonuclear neutrophils. 
However, the content of macrophage was returned to 
95% during the following 3 days and slightly diminished 
to 80% 4 days later. Thus, it is likely that the change of 
the TX synthase mRNA level by casein corresponded to 
the relative cell population of macrophage in isolated 
peritoneal cells. Previously, Ni.ising et al. [19] reported 
that neither TX synthase nor its enzyme activity could 
be demonstrated in purified human granulocytes. Fur- 
thermore, Tripp et al. [20] showed that TX synthase 
activity was unchanged in activated mouse peritoneal 
macrophages. These facts may suggest hat TX synthase 
mRNA in peritoneal cells was mostly derived from peri- 
toneal macrophages and the mRNA level in rat perito- 
neal macrophages did not change by stimulation with 
casein. 
Fig. 2B shows the tissue specificity of the expression 
of the rat TX synthase gene. Only one band with a size 
of approximately 2.2 kb was observed by RNA blot 
analysis. During the course of the present study, Zhang 
et al. reported the cloning of mouse TX synthase cDNA 
and showed that the size of the transcript of the TX 
synthase gene in mouse kidney was about 100 to 150 bp 
shorter than those in lung and spleen [171. Such a shorter 
transcript, however, was not found in rat kidney. Bone 
marrow was the organ richest in TX synthase mRNA 
followed by spleen, lung and thymus. The expression was 
also observed in liver, kidney and uterus, and a low but 
significant amount of the mRNA was seen in brain and 
heart. It is less possible that the TX synthase mRNA 
detected in brain and heart were caused by the contami- 
nation of blood cells, because they contained little TX 
synthase mRNA (Fig. 2A). The tissue distribution of rat 
TX synthase mRNA almost agreed with those of the 
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5'--- GGATGGGATGTTTGCTCATTACATATTCCTTCCTTCACT -91 
GCCTACACACAGCTCAGGACTCCTATMGGGCAGGACACGCTGATC~CTCTCC~CTAGG~G~CCCCTCTGGGGTCTCAGAffi~ -1 
ATGGMGTGTTGGGGCTTCTCMGTTCGAAGT~G~G~AGTGGTACCGTAGTGACTGTGACTCTGTCCGTGGTTCTCTTGGCCCTCCTG~TGG 
MEVLGLLKFEVSGTVVTVTLSVVLLALLKW 
90 
30 
TACTCCACATCAGCGTTCTC~GACTGGGCAGTTTTTCCGC 
YSTSAFSRLRKLGIRHPEPSPFVGNLMFFR 
180 
60 
CAGGGCTTTTGGG~AGCCATTTGGACCTCCGAGAGCCGAGAGCGATATG~CCTCTGTGT~TACTATCTTffiCCGTCGGATGTACATTGTCATT 
QGFWESHLELRERYGPLCGYYLGRRMYIVI 
270 
90 
TCAGACCCAGACATGATC~GGAGGTGTTGGTTGGTTGAG~CTTCAGT~CTTTTCC~CAG~TGGCC~AGGTCTGG~CCC~GCTGATA 
SDPDMIKEVLVEWFSNFSNRMASGLEPKLI 
360 
120 
GCAGACAGTGTCCTGATGTTACGTGACAGMGATGGGAGCGAG 
ADSVLMLRDRRWEEVRGALHSAFSPEKLNE 
450 
150 
ATGACACCTCTCATCAGCCAAGCCTGTGAACTTCTCCTG 
MTPLISQACELLLSHLKHSAASGDAFDIQR 
540 
180 
TGTTACTGCTGTTTTACCACAAATGTGTGGTGGCCAGTG~GCCTTTGGCATCGAGGTG~CTCCCAGGATGCTCCAG~GACCCCTTTGTG 
CYCCFTTNVVASVAFGIEVNSQDAPEDPFV 
630 
210 
CAPICACTGCCAGCGTGTTTTTGCTTTCAGTACCCIUGGTGGTCCCATTGGCC 720 
QHCQRVFAFSTPRPLLALILSFPSIMVPLA 240 
CGGATTCTGCCCAATAAGACGAGATG~CTGGCTCA 
RILPNKNRDELNGFFNTLIRNVIALRDKQT 
810 
210 
GCAGllAGAGAGGCGGGGAGACTTCCTGCAGATGGTGCTGGGTC 
AEERRGDFLQMVLDAQRSHSSVGVEAFDMV 
900 
300 
ACAGMGCCCTGTCCTCTGCTGAGT~ATGGU;GICC 
TEALSSAECHGDPPQRCHPTSTAKPLTVDE 
990 
330 
ATTGCCGGCCAGGCTTTCCTCTTCCTCATCGCTGGCCACGAGATCACCAC~CACGCTCTCCTTCATCACATACCTGCTGGCCACCCAC 
IAGQAFLFLIAGHEITTNTLSFITYLLAT" 
1080 
360 
CCTGAGTGCCAGGAGAGGCTTCTGAAAGAGGTGGACCTCTTCATGGAG~GCATCCAGCCCCTGAGTACTGC~CCT~AGG~ffiTCTG 
PECQERLLKEVDLF"EKHPAPEYCNLQEGL 
1110 
390 
CCCTATCTGGACATGGTGGTTGCAGAGACCCCTGAGGA~TACCCACCA~TTTC~ATTCAC~GGGA~CA~ACAGGACTGTGAGGTG 1260 
PYLDMVVAETLRMYPPAFRFTREAAQDCEV 420 
Cn;GGACCAGCACATCCCTGCAGGTTCTGTGCTGGAGlrTGACC 
LGQHIPAGSVLEIAVGALHHDPEHWPNPET 
1350 
450 
1440 
480 
GGAGTACGGCTGGGGCTGCTGGTGG~MGCTTCAGGTT 
GVRLGLLVVKLTLLQVLEKFRFEACPETQV 
1530 
510 
CCACTTCAGCTAGI\ATCCAAATCTGCTCTGCTCTAT~CCC~TG~GTCTACGTCMGATTGTGTCACGCTGACATAG~GGCAGGTGTGA 1620 
PLQLESKSALCPKNGVYVKIVSR' 533 
AAGAGGAAGCACTTTGT~TAGTGACGTCTGTGCATCACTGTT~GAG~CGCCATTTATGTCACAGTTCT~TGTT~~TGTTT 1110 
GKATGCTTC ---3' 1720 
Fig. 1. Rat thromboxane synthase. (A) Restriction map of cDNA encoding rat TX synthase. pRTXS1 was obtained by screening a megakaryocyte 
library and pRTXS2-2 was obtained by PCR as described in section 2. Only the relevant restriction sites are shown in this map. The protein-coding 
region is indicated by an open box, and the primer used for PCR is designated by Pl. The direction and extent of sequencing are shown by arrows. 
(B) The nucleotide sequence of rat TX synthase cDNA and the deduced amino acid sequence of the enzyme. Nucleotides are numbered starting from 
the first nucleotide A of the translational initiation codon ATG, and amino acid residues are numbered starting from N-terminal methionine of the 
deduced primary structure of the rat enzyme. The underlined decapeptide indicates the conserved putattve heme-binding site. The polyadenylation 
signal AATAAA is indtcated by double underline. The poly(A) tract is not shown here. 
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Fig. 2. Expression of the rat TX synthase gene. (A) RNA blot analysis of total RNAs (20,@ane) from blood cells and peritoneal cells: lane 1, platelets; 
lane 2, leukocytes; lane 3, resident peritoneal cells; lane 4, day 1 peritoneal cells post casein treatment; lane 5, day 4 peritoneal cells post casem 
treatment; lane 6, day 8 peritoneal cells post casein treatment. (B) RNA blot analysis with poly(A)’ RNA (5 &lane) from rat tissues: lane 1, brain; 
lane 2. lung; lane 3, heart; lane 4, thymus; lane 5, liver; lane 6. spleen; lane 7, kidney; lane 8, testis; lane 9, uterus; lane 10. bone marrow. 
human TX synthase enzyme protein and the specific en- 
zyme activity [19], and was essentially identical with that 
of mouse TX mRNA [17]. The high levels of the expres- 
sion of the TX synthase gene in spleen and thymus may 
reflect the mRNA of macrophages and dendric cells, 
because those cells in human were reported to have a TX 
synthase activity as high as platelets [19]. Recently, 
Namba et al. reported that mouse thymus and spleen 
were the organs rich in the TXA, receptor expression and 
suggested that the TXA, receptor is involved in and 
modulates immune responses [21]. In this context, our 
result that TX synthase mRNA is highly expressed in rat 
thymus and spleen, strongly supports the idea that TXAz 
plays a role in the immune system. 
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